125 related articles for article (PubMed ID: 15924606)
21. How significant is a cervical smear showing glandular dyskaryosis?
Pisal NV; Sindos M; Desai S; Mansell E; Singer A
Eur J Obstet Gynecol Reprod Biol; 2003 Jun; 108(2):209-12. PubMed ID: 12781413
[TBL] [Abstract][Full Text] [Related]
22. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
23. High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance.
Denise Zielinski G; Snijders PJ; Rozendaal L; Voorhorst FJ; Runsink AP; de Schipper FA; Meijer CJ
J Pathol; 2001 Oct; 195(3):300-6. PubMed ID: 11673826
[TBL] [Abstract][Full Text] [Related]
24. The role of early colposcopy in the management of females with first episode anogenital warts.
Ward KA; Houston JR; Lowry BE; Maw RD; Dinsmore WW
Int J STD AIDS; 1994; 5(5):343-5. PubMed ID: 7819352
[TBL] [Abstract][Full Text] [Related]
25. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
[TBL] [Abstract][Full Text] [Related]
26. A case-control study of true-positive versus false-negative cervical smears in women with cervical intraepithelial neoplasia (CIN) III.
O'Sullivan JP; A'Hern RP; Chapman PA; Jenkins L; Smith R; al-Nafussi A; Brett MT; Herbert A; McKean ME; Waddell CA
Cytopathology; 1998 Jun; 9(3):155-61. PubMed ID: 9638376
[TBL] [Abstract][Full Text] [Related]
27. The comparative diagnostic accuracy of conventional and liquid-based cytology in a colposcopic setting.
Hussein T; Desai M; Tomlinson A; Kitchener HC
BJOG; 2005 Nov; 112(11):1542-6. PubMed ID: 16225576
[TBL] [Abstract][Full Text] [Related]
28. Prospective parallel randomized trial of the MultiCyte™ ThinPrep(®) imaging system: the Scottish experience.
Palmer TJ; Nicoll SM; McKean ME; Park AJ; Bishop D; Baker L; Imrie JE
Cytopathology; 2013 Aug; 24(4):235-45. PubMed ID: 22616770
[TBL] [Abstract][Full Text] [Related]
29. An audit of the positive predictive value of high-grade dyskaryosis in cervical smears: 2001-2002.
Wadehra V; Johnson SJ
Cytopathology; 2003 Jun; 14(3):107-14. PubMed ID: 12828718
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 and 18 detection in the management of mild dyskaryosis.
Cruickshank ME; Buchan S; Melvin WT; Kitchener HC
Br J Obstet Gynaecol; 1999 Sep; 106(9):969-76. PubMed ID: 10492111
[TBL] [Abstract][Full Text] [Related]
31. The suitability of DNA cytometry for the prediction of the histological diagnosis in women with abnormal cervical smears.
van Leeuwen AM; Ploem-Zaaijer JJ; Pieters WJ; Hollema H; Burger MP
Br J Obstet Gynaecol; 1996 Apr; 103(4):359-65. PubMed ID: 8605134
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of adjunctive HPV testing by Hybrid Capture II in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy.
Guyot A; Karim S; Kyi MS; Fox J
BMC Infect Dis; 2003 Sep; 3():23. PubMed ID: 14511396
[TBL] [Abstract][Full Text] [Related]
33. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
[TBL] [Abstract][Full Text] [Related]
34. Decision analysis for best management of mildly dyskaryotic smear.
Johnson N; Sutton J; Thornton JG; Lilford RJ; Johnson VA; Peel KR
Lancet; 1993 Jul; 342(8863):91-6. PubMed ID: 8100917
[TBL] [Abstract][Full Text] [Related]
35. Use of the ThinPrep Imaging System for internal quality control of cervical cytology.
Heard T; Chandra A; Culora G; Gupta SS; Herbert A; Morgan M
Cytopathology; 2013 Aug; 24(4):246-53. PubMed ID: 22937891
[TBL] [Abstract][Full Text] [Related]
36. Colposcopic management of high-grade referral smears: a retrospective audit supporting 'see and treat'?
Errington CA; Roberts M; Tindle P; Michael E; Bulmer JN; Wadehra V
Cytopathology; 2006 Dec; 17(6):339-47. PubMed ID: 17168916
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of high grade dyskaryotic cervical smears likely to be missed on rapid rescreening.
O'Sullivan JP; Chapman PA; Jenkins L; Smith R
Acta Cytol; 2000; 44(1):37-40. PubMed ID: 10667157
[TBL] [Abstract][Full Text] [Related]
38. Management of women with low grade cytology: how reassuring is a normal colposcopy examination?
Cruickshank ME; Cotton SC; Sharp L; Smart L; Walker LG; Little J;
BJOG; 2015 Feb; 122(3):380-6. PubMed ID: 24947656
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for high-grade cervical intraepithelial neoplasia in patients with mild cytological dyskaryosis: human papillomavirus testing versus multivariate tree analysis of demographic data.
Sideri M; Spinaci L; Schettino F; Mezzetti M; Robertson C; Spolti N; Di Pace R; Crosignani P
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):237-41. PubMed ID: 9521440
[TBL] [Abstract][Full Text] [Related]
40. The cytological prediction of cervical intraepithelial neoplasia in colposcopically directed biopsies.
Parham DM; Wiredu EK; Hussein KA
Cytopathology; 1991; 2(6):285-90. PubMed ID: 1801949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
